Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS

被引:2
|
作者
Wang, Wei [1 ]
Khoury, Joseph D. [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[2] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
关键词
D O I
10.1002/cyto.b.22110
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:12 / 14
页数:3
相关论文
共 50 条
  • [41] Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)
    Oelschlaegel, Uta
    Mohr, Brigitte
    Sockel, Katja
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    BLOOD, 2016, 128 (22)
  • [42] Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India
    Dhingra, Gaurav
    Dass, Jasmita
    Arya, Vandana
    Gupta, Nitin
    Saraf, Amrita
    Langer, Sabina
    Aggarwal, Shyam
    Kotwal, Jyoti
    Bhargava, Manorama
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (03) : 254 - 262
  • [43] CORRECT UNDERSTANDING THE VALUE AND ROLE OF FLOW CYTOMETRY IN HEMATOLOGICAL NEOPLASMS DIAGNOSIS
    Yue, Baohong
    Sun, Xiaoli
    Jia, Yu
    Wei, Yuanyu
    Liu, Shuai
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84 (06) : 425 - 425
  • [44] Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
    Porwit, A.
    van de Loosdrecht, A. A.
    Bettelheim, P.
    Brodersen, L. Eidenschink
    Burbury, K.
    Cremers, E.
    Della Porta, M. G.
    Ireland, R.
    Johansson, U.
    Matarraz, S.
    Ogata, K.
    Orfao, A.
    Preijers, F.
    Psarra, K.
    Subira, D.
    Valent, P.
    van der Velden, V. H. J.
    Wells, D.
    Westers, T. M.
    Kern, W.
    Bene, M. C.
    LEUKEMIA, 2014, 28 (09) : 1793 - 1798
  • [45] An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
    Mughal, Tariq I.
    Cross, Nicholas C. P.
    Padron, Eric
    Tiu, Ramon V.
    Savona, Michael
    Malcovati, Luca
    Tibes, Raoul
    Komrokji, Rami S.
    Kiladjian, Jean-Jacques
    Garcia-Manero, Guillermo
    Orazi, Attilio
    Mesa, Ruben
    Maciejewski, Jaroslaw P.
    Fenaux, Pierre
    Itazykson, Raphael
    Mufti, Ghulam
    Solary, Eric
    List, Alan F.
    HAEMATOLOGICA, 2015, 100 (09) : 1117 - 1130
  • [46] Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS) - Composition of a Prognostic FCM-Score for Overall Survival
    Oelschlaegel, Uta
    Santaolalla, Aida
    Timms, Jessica A.
    Winter, Susann
    Sockel, Katja
    Bornhaeuser, Martin
    Farzaneh, Farzin
    Harrison, Claire N.
    Westers, Theresia M.
    van de Loosdrecht, Arjan
    Van Hemelrijck, Mieke
    Platzbecker, Uwe
    Kordasti, Shahram
    BLOOD, 2021, 138
  • [47] THE NEW FLOW CYTOMETRY IN MYELODYSPLASTIC SINDROMES (MDS): FROM CD34+ PRECURSORS TO PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) CLONES
    Del Vecchio, L.
    CYTOMETRY PART A, 2011, 79A (12) : 1028 - 1029
  • [48] Independent prognostic value of flow cytometry (FCM) in myelodysplastic syndromes (MDS): Composition of a prognostic FCM-score for overall survival
    Santaolalla, A.
    Oelschlaegel, U.
    Timms, J.
    Winter, S.
    Parker, P.
    Harrison, C. N.
    Westers, T. M.
    van de Loosdrecht, A. A.
    van Hemelrijck, M.
    Platzbecker, U.
    Kordasti, S.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1396 - S1396
  • [49] Use of multiparametric flow cytometry analysis (six-color) for the detection of leukemia associated immunophenotypes (LAIP) in myelodysplastic syndromes (MDS)
    Campos, L.
    Flandrin, P.
    Nadal, N.
    Tinat, J.
    Guyotat, D.
    LEUKEMIA RESEARCH, 2007, 31 : S87 - S87
  • [50] Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment
    Burbury, Kate L.
    Westerman, David A.
    LEUKEMIA & LYMPHOMA, 2014, 55 (04) : 749 - 760